Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

To investigate the role of gefitinib in patients with high-grade gliomas (HGGs), a phase II trial (1839IL/0116) was conducted in patients with disease recurrence following surgery plus radiotherapy and first-line chemotherapy. Adult patients with histologically confirmed recurrent HGGs following sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Franceschi, E, Cavallo, G, Lonardi, S, Magrini, E, Tosoni, A, Grosso, D, Scopece, L, Blatt, V, Urbini, B, Pession, A, Tallini, G, Crinò, L, Brandes, A A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360116/
https://www.ncbi.nlm.nih.gov/pubmed/17353924
http://dx.doi.org/10.1038/sj.bjc.6603669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360116/
https://www.ncbi.nlm.nih.gov/pubmed/17353924
http://dx.doi.org/10.1038/sj.bjc.6603669

Ejemplares similares